Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-25

Clinical Trial Update: Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations [NA]

View source ↗

Summary

Completed clinical trial evaluating heparin prophylaxis to reduce exacerbations in hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heparin (unfractionated heparin)

Snippet

Sponsor: University of Iowa | Conditions: Angioedema | NA | Status: COMPLETED